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Abstract
2q  .The effects of extracellular Ca on cytotoxicity induced by cardiotoxin CTX , isolated from Chinese cobra venom,
 .  .were investigated in cultured rabbit aortic endothelial cells RAECs . In Hank’s buffered saline solution HBSS containing
2q  .1.2 mM Ca , CTX 1–30 mM caused cell necrosis and cell death in a concentration-dependent manner, as determined by
trypan blue exclusion test performed after a 20-min CTX treatment. The concentration of CTX that caused 50% cell death
 . 2qwas about 6.5 mM. CTX 10 mM -induced RAEC damage was also evident but less prominent in Ca -free medium and
almost completely prevented in medium containing 7–10 mM Ca2q. Therefore, Ca2q appears to provoke CTX-induced
injury at physiological concentrations, but protects against it at high concentrations. The protection of RAECs from
CTX-induced injury could also be achieved by high concentrations of Ni2q and Mg2q. Using the fura-2 fluorescence
2q w 2qx .technique to measure the cytosolic free Ca concentration Ca of single RAEC, it was shown that in 1.2 mMi
Ca2q-containing HBSS, treatment of RAECs with 10 mM CTX for 7–35 min resulted in a tremendous and irreversible
w 2qx 2q 2qCa elevation, suggestive of cell membrane damage and extracellular Ca entry. Ni could also enter the cytosol ofi
w 2qx 2qthese damaged RAECs. However, there was no Ca elevation or Ni entry in RAECs that were preincubated in HBSSi
containing 7 mM Ca2q or Ni2q before CTX exposure. In RAECs protected with 7 mM Ca2q, the intracellular Ca2q signals
triggered by 100 mM extracellular ATP or 10 mM bradykinin in CTX-treated groups were similar to those in the untreated
control groups. Taken together, the results indicate that high extracellular Ca2q concentrations protected RAECs from
CTX-induced injury, and preserved the ability of CTX-treated RAECs to generate Ca2q signals in response to physiological
stimuli. q 1997 Elsevier Science B.V.
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1. Introduction
 .Cardiotoxin CTX is a membrane-active polypep-
tide that has been purified from cobra snake venom
w x1 . It exerts many effects, including membrane depo-
larization, contraction of cardiac and skeletal mus-
cles, and modulation of a number of enzymes, such
as phospholipase C and the plasmalemmal Ca2q pump
w x2,3 . CTX has also been named cytotoxin or direct
lytic factor because continuous exposure to this toxin
w xleads to hemolysis and cytolysis 4–7 . The manner
by which CTX interacts with the plasma membrane is
not fully understood, but there is evidence that sug-
gests that the positively charged amino acid residues
of CTX interact with some anionic domains of the
plasmalemmal lipid molecules, thus leading to disor-
w xganization of the plasma membrane 8–11 . In con-
cordance with this notion, it has been shown that high
concentrations of extracellular Ca2q can prevent the
action of CTX, presumably by competing with CTX
for the same anionic sites. For instance, Chen et al.
w x w x 2q12 and Jiang et al. 6 reported that 10 mM Ca
w xinhibited CTX-induced hemolysis. Leung et al. 4
also demonstrated that CTX-induced cytolysis of
Ehrlich ascites tumor cells was attenuated by high
Ca2q concentrations. In addition, high Ca2q concen-
trations also inhibited the contracture of skeletal and
w xcardiac muscles that was triggered by CTX 13–15 .
High concentrations of Ca2q could also block the
binding of radiolabeled CTX to membranes of axons
w x w x w x8 , skeletal muscles 13 and erythrocytes 16 .
Vascular endothelial cells respond to many vasoac-
tive substances by releasing a number of factors, such
as the endothelium-derived relaxation factor now
.known as nitric oxide and endothelin, which can
modulate the tone of the underlying vascular smooth
w xmuscle 17 . The endothelium is in immediate contact
with CTX, once this toxin invades the circulatory
system. We previously showed that, in endothelium-
intact rat aortic rings, CTX-induced contraction was
preceded by a small and transient relaxation and that
CTX could also transiently suppress phenylephrine-
induced contraction in an endothelium-dependent
w xmanner 18 . These functional studies suggest that
CTX damaged the endothelial plasmalemma, thus
permitting Ca2q influx and subsequent nitric oxide
release. However, despite the well-recognized hemo-
dynamic effects of CTX, direct toxic effects of CTX
on isolated endothelial cells have not been demon-
strated hitherto. Whether or not high levels of Ca2q
can also protect endothelial cells from CTX-induced
injury is therefore unknown. Furthermore, previous
studies on CTX effects used either cell membranes or
 .a group population of cells, and there has not been
any work reporting changes in single cells after CTX
treatment. In this study, using the trypan blue exclu-
sion test and the fura-2 microfluorimetric technique
w 2qxto measure Ca in single cells, it was shown thati
in 1.2 mM Ca2q-containing HBSS, treatment of rab-
 .bit aortic endothelial cells RAECs with CTX led to
w 2qxa substantial Ca elevation prior to plasma mem-i
brane damage and eventual cell lysis. However,
RAECs preincubated in medium containing high Ca2q
 .levels 7–10 mM were protected from CTX-induced
injury. Although there have been many reports show-
2q  .ing that high Ca or divalent cation concentrations
could protect cells from CTX-induced structural dam-
age, whether functional integrity is preserved or not
in these protected cells has not been demonstrated
hitherto. Here, we show that CTX-treated RAECs
that were protected by high levels of Ca2q could
2q  .generate Ca signals in response to agonists , simi-
lar to those of untreated cells, suggesting that high
levels of Ca2q could maintain the functional integrity
of CTX-challenged endothelium.
2. Materials and methods
2.1. Materials
Medium 199, penicillin, streptomycin and fetal
 .bovine serum FBS were obtained from Gibco BRL
 .Gaithersburg, MD, USA . Fura-2 AM, trypan blue,
mepacrine, neomycin and ATP were purchased from
 .Sigma St. Louis, MO, USA . Bradykinin was pur-
chased from Peninsula Laboratories, Belmont, CA,
.USA . CTX was purified from the venom of Naja
naja atra by a three-step column chromatography
w xmethod, as previously described 15 . Phospholipase
 . A PLA activity was found to be very low 0.05–2 2
.0.15% in the purified CTX using a standard pH–stat
w xassay 15 . Mepacrine, an inhibitor of PLA , did not2
 .prevent the cytotoxic action of CTX see Section 3 ,
suggesting that the CTX-induced cytotoxicity was not
due to the trace amount of contaminating PLA .2
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Neurotoxin was also purified from the same snake
 .venom by carboxymethyl CM Sephadex G-25 col-
w xumn chromatography 15 . All other chemicals were
of reagent grade.
2.2. Culture of endothelial cells
Endothelial cells were isolated from the thoracic
aorta of New Zealand white rabbits weighing 1.5 to
.2.5 kg in the following manner. Under sterile condi-
tions, the thoracic aorta was removed and placed in
 . 2qHank’s balanced salt solution HBSS without Ca
2q  .and Mg Gibco . After careful removal of the
surrounding fat and connective tissue, the luminal
surface was incubated in HBSS containing 0.25%
 .trypsin and 1 mM EDTA Gibco for 5 min at 378C.
Thereafter, the luminal surface was gently flushed
with Medium 199 supplemented with 20% FBS,
 .  .penicillin 100 Urml and streptomycin 100 mgrml
 .enriched Medium 199 . The effluent was collected
 .and centrifuged 200 g for 10 min. The cell pellet
was resuspended in enriched Medium 199 and seeded
onto six-well tissue culture plates Costar, Cam-
.bridge, MA, USA . The cells were maintained in the
same culture medium in a humidified atmosphere of
5% CO at 378C and were passaged about once a2
week. HBSS containing 0.05% trypsin and 0.53 mM
 .EDTA Gibco was used to detach cells. All RAECs
used in this study were between passage numbers
four and ten.
The identity of the endothelial cells was indicated
 .by their typical cobblestone appearance Fig. 3a and
confirmed by positive immunofluorescence using an
 .anti-von Willebrand factor VIII antibody Sigma
 .not shown .
2.3. Determination of cell ˝iability
 .HBSS, composed of mM 138 NaCl, 5.3 KCl, 0.8
MgSO , 1.2 CaCl , 0.44 KH PO , 0.34 Na HPO , 54 2 2 4 2 4
glucose and 25 HEPES, buffered at 7.4, was used for
washing and incubation. RAECs were gently washed
once and cell viability was examined by the trypan
 .blue 0.1% final concentration exclusion test, which
was performed after treatment with or without CTX
 .for 20 min except in Fig. 5 at room temperature. In
each experiment, 100 cells in each treatment group
were counted at random under a light microscope.
2.4. Fura-2 fluorescence measurement in a single
RAEC
2q w 2qx .The cytosolic free Ca concentration Ca ini
a single RAEC was measured using the Ca2q-sensi-
tive fluorescence dye, fura-2. HBSS, having the com-
position mentioned above, was used for washing and
for fluorescence measurements. RAECs were grown
on glass coverslips for 24–48 h, washed once with
HBSS and then incubated in Medium 199 containing
2% FBS and 1 mM fura-2 acetoxy methylester for 30
min at 378C. Thereafter, the fura-2-loaded cells were
washed twice with HBSS, bathed in 500 ml of HBSS
and the coverslip was mounted in a small plastic
chamber. The latter was then put on the stage of an
 .inverted microscope Nikon, Tokyo, Japan . Single
cells were selected using a rectangular diaphragm
that was fitted into the emission port of the micro-
scope, which was, in turn, coupled to a photomulti-
plier of the fluorescence instrument Photon Technol-
.ogy International, South Brunswick, NJ, USA . The
selected cell was excited alternately at 340 and 380
nm and the emitted fluorescence was detected at 510
nm. After the fluorescence signals stabilized, drugs or
 .agonists were added in small volumes F5 ml fol-
lowed by very gentle mixing. All experiments were
performed at room temperature.
Fig. 1. CTX caused the concentration-dependent death of RAECs.
Cells in HBSS containing 1.2 mM Ca2q were treated with
different concentrations of CTX for 20 min prior to a trypan blue
exclusion test. Results are expressed as the mean"SE of four
separate experiments.
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Fig. 2. Effects of extracellular Ca2q concentration on CTX-in-
duced RAEC death. Cells in HBSS containing various concentra-
2q  . tions of Ca were incubated with solid circle or without open
.  .circle CTX 10 mM for 20 min and cell viability was then
examined. Under Ca2q-free conditions, 50 mM EGTA was added.
Results are expressed as the mean"SE of six separate experi-
ments. An ) indicates statistical significance compared to CTX-
2q  .treated RAECs in HBSS containing 1.2 mM Ca P -0.05 .
2.5. Statistical analysis
The results were expressed as mean"SEM. The
Student’s paired t-test was employed and differences
were considered significant when P-0.05.
3. Results
 .Fig. 1 shows that CTX 1–30 mM caused cell
death in 1.2 mM Ca2q medium in a concentration-de-
Fig. 4. The protective effects of high Ca2q, Ni2q and Mg2q on
CTX-induced cell death. Cells were initially bathed in 1.2 mM
Ca2q-containing HBSS. Various concentrations of Ca2q, Ni2q
2q  .and Mg , and CTX 10 mM were then added for 20 min prior
to the trypan blue exclusion test. Results are expressed as the
mean"SE of four separate experiments. ) The protective effect
of Mg2q was significantly less prominent than that of Ca2q or
2q  .Ni P -0.05 .
pendent manner. The concentration of CTX that
caused 50% cell death was about 6.5 mM. As a
negative control, neurotoxin, also present in snake
venom and having structural similarity to CTX, did
not cause cell death, even at a concentration of 50
 .mM cell viabilitys99.7"0.3%; ns3 . Fig. 2
shows that extracellular Ca2q exhibited a concentra-
tion-dependent biphasic effect on CTX-induced cyto-
toxicity. CTX-induced cytotoxicity was higher in 1.2
mM Ca2q-containing HBSS than in Ca2q-free HBSS.
However, increasing the concentration of Ca2q in
2q  . 2qFig. 3. Protective effect of high levels of Ca on CTX-induced RAEC damage. a Untreated control cells in 1.2 mM Ca -containing
 .  . 2qHBSS. b and c Cells were treated with 10 mM CTX in HBSS containing, 1.2 and 7 mM Ca for 20 min, respectively. Thereafter,
 .trypan blue 0.1% final concentration was added. Magnifications400= .
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Fig. 5. The effect of the washing out of CTX on cell death during
the course of CTX treatment. RAECs were initially bathed in 1.2
2q 2q  .mM Ca or 7 mM Ca -containing HBSS. CTX 10 mM was
then added and cell death was determined at 2, 6 and 15 min
 .  .open triangle, square . CTX 10 mM was also added to other
groups, which were washed extensively for 30 s with 1.2 mM
2q  .Ca -containing HBSS at 2, 6 or 15 min circle, closed triangle .
These groups were then bathed in 1.2 mM Ca2q-containing
HBSS for a further 13, 9 or 0 min, respectively, before the trypan
blue exclusion test was performed. Results are expressed as the
mean"SE of five separate experiments.
HBSS attenuated CTX-induced cytotoxicity so that in
7–10 mM Ca2q HBSS, nearly all cells were pro-
tected. CTX-induced cytotoxicity and the protective
effects of high Ca2q were also obvious when cell
morphology was examined. Fig. 3a and b show,
respectively, the morphology of RAEC incubated in
 .the absence and presence of CTX 10 mM in 1.2
mM Ca2q HBSS for 20 min. The majority of CTX-
treated cells exhibited necrosis and were stained with
trypan blue. However, in 7 mM Ca2q HBSS, almost
all the CTX-treated cells retained normal morphology
 .Fig. 3c .
We also tested to see if other divalent cations
could prevent CTX-induced cytotoxicity in RAECs.
Fig. 4 shows that high concentrations of Ni2q were
as effective as high concentration of Ca2q in inhibit-
ing the action of CTX. Mg2q also elicited a substan-
tial protective effect, but was significantly less effec-
2q 2q  .tive than Ca or Ni P-0.05 .
We next tested the reversibility of CTX action
 .Fig. 5 . Treatment of RAECs with 10 mM CTX in
1.2 mM Ca2q medium resulted in a time-dependent
w 2qx 2q  .Fig. 6. The effect of CTX on Ca of a single RAEC. A fura-2-loaded RAEC in 1.2 mM Ca -containing HBSS a and b or 7 mMi
2q  .  .Ca -containing HBSS c was treated with 10 mM CTX arrow . The y-axis represents the fura-2 fluorescence ratio of 340 nmr380 nm.
w 2qx w 2qx  .Small fluctuations in Ca before the substantial Ca elevation a was observed in eight out of eleven cells, while the other threei i
w 2qx  .  .  .  .cells did not exhibit fluctuation before the large Ca surge b . In a and b , there was a variation in the time 7–35 min betweeni
 .  .CTX exposure and the abrupt increase ‘‘burst’’ in the ratio value. The result shown in c was observed in at least three other cells
 .  .  .  .  .  .  .  .tested. d , e and f show the corresponding fluorescence at 340 nm upper trace and 380 nm lower trace of samples a , b and c ,
respectively.
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increase in cell death. If RAECs were treated with
CTX for 2 min, then washed extensively and checked
for viability after 13 min, the degree of cytotoxicity
was similar to that observed at the 2-min time point.
This result suggests that CTX could be washed away
so that there was no further cell damage during the
13 min incubation. A similar result was obtained at
2q  .the 6-min time point. Ca 7 mM offered almost
complete protection against CTX-induced cytotoxic-
ity at all time points, regardless of whether the
‘‘wash-out’’ protocol was employed or not.
CTX has been known to activate PLA and phos-2
w xpholipase C 3 . We investigated if the CTX-induced
toxicity was due to activation of these enzymes.
 .Mepacrine 100 mM, an inhibitor of PLA did not2
prevent CTX-induced cytotoxicity in Ca2q-containing
medium cell viabilitys4.4"1.0% in CTX-treated
group versus 5.1"1.1% in CTX- and mepacrine-
. 2q treated group; ns8 or Ca -free medium cell via-
bilitys17.1"0.7% in CTX-treated group versus
14.2"1.0% in CTX- and mepacrine-treated group;
. ns8 . Neomycin 100 mM, an inhibitor of phospho-
.lipase C also did not prevent CTX-induced cytotoxi-
2q city in Ca -containing medium cell viabilitys5.9
"0.7% in CTX-treated group versus 6.6"0.8% in
. 2qCTX- and neomycin-treated group; ns8 or Ca -
free medium cell viabilitys16.4"1.0% in CTX-
treated group versus 16.1"1.4% in CTX- and
.neomycin-treated group; ns8 . Therefore, activation
of PLA and phospholipase C did not appear to2
mediate the cytotoxic action of CTX.
The protective effects caused by high concentra-
tions of divalent cations on CTX-induced membrane
damage were also demonstrated using the fura-2 fluo-
rescence technique. In HBSS containing 1.2 mM
2q  .Ca , a single RAEC treated with CTX 10 mM
showed a tremendous 340 nmr380 nm fluorescence
. w 2qxratio )20 Ca elevation after a variable periodi
 .of 7–35 min 26.5"4.2 min; ns11; mean"SEM
 . w 2qxFig. 6a–b . A smaller Ca elevation was ob-i
w 2qxserved prior to the tremendous Ca elevation ini
 .eight out of eleven cells tested Fig. 6a . Fig. 6d–e
 .show the fluorescence changes at 340 and 380 nm
of the experiment shown in Fig. 6a–b, respectively.
The fluorescence changes at these two wavelengths
were opposite i.e., rise and fall at 340 and 380 nm,
. w 2qxrespectively and, therefore, genuinely reflects Ca i
elevation. Note that at the very late stage, the ratio
fluctuated dramatically and subsequently dropped to
 .zero Fig. 6a–b . The corresponding fluorescence at
340 and 380 nm also eventually dropped to zero Fig.
.6d–e , probably due to the leakage of fura-2 from the
severely damaged single cell, being infinitely diluted
by the large volume of the extracellular medium. The
addition of 7 mM Ca2q during or immediately after
w 2qxthe large Ca elevation did not prevent the celli
 .from disruption not shown . However, there was no
w 2qxpersistent elevation in Ca in CTX-treated RAECsi
for 40 min, if the HBSS already contained 7 mM
2q Ca at the beginning of the experiment Fig. 6cFig.
. 2q6f . The protective effect of high Ca concentrations
2q  .could also be achieved by 7 mM Ni Fig. 7 ,
which quenches fura-2 fluorescence at all excitation
w xwavelengths 19 . When RAECs were treated with 10
Fig. 7. High Ni2q prevented CTX-induced plasma membrane
 .  .leakiness in single RAECs. In a and b , the upper and lower
traces represent fura-2 fluorescence at 340 and 380 nm, respec-
 . 2qtively. a A fura-2-loaded RAEC in 1.2 mM Ca -containing
HBSS was exposed to 10 mM CTX. As soon as the fluorescence
at 340 and 380 nm began to increase and decrease, respectively,
2q  .7 mM Ni was added. b A fura-2-loaded RAEC in 1.2 mM
Ca2q-containing HBSS was treated with 7 mM Ni2q before
 .CTX 10 mM challenge. Similar results were obtained in four
 .other separate experiments. In a , there was a variation in the
 .time 7–30 min between CTX exposure and the changes in
fluorescence at both wavelengths.
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mM CTX in 1.2 mM Ca2q HBSS for some 3–30
min, there was an increase and decrease in fura-2
fluorescence at 340 and 380 nm, respectively, indicat-
ing Ca2q influx and, hence, CTX-induced permeabi-
 . 2qlization Fig. 7a . When Ni was then added, the
fura-2 fluorescence at both 340 and 380 nm was
completely quenched, indicating the entrance of Ni2q
into the cytosol. However, when RAECs were prein-
cubated with Ni2q before CTX treatment, there was
no change in fluorescence at both wavelengths for 40
 . w 2qxmin Fig. 7b , suggesting that neither Ca eleva-i
tion nor Ni2q entry took place. The results in Figs. 6
and 7 thus suggest that high Ca2q- or Ni2q concen-
trations could prevent CTX-induced membrane dam-
age.
The results obtained so far indicate that high con-
centrations of divalent cations could maintain the
structural integrity of the plasma membrane of CTX-
treated RAECs, thus preventing the cells from mem-
brane leakiness and necrosis. However, whether such
protected cells remain functionally intact or not is
unclear. One approach to examine this is to test how
well the protected RAECs respond to physiological
agonists by generating Ca2q signals. In cells bathed
in 1.2 mM Ca2q, or 7 mM Ca2q, or cells bathed in 7
mM Ca2q and treated with 10 mM CTX, bradykinin
w 2qxevoked a surge in Ca , followed by a graduali
decline to a plateau level that was slightly above the
w 2qx  .resting Ca Fig. 8a–c . There is no significanti
difference in magnitude between the bradykinin-
2q  .stimulated Ca responses peak and tonic under the
 .three different conditions used Fig. 8d . Similar
results were obtained when extracellular ATP was
 .used as an agonist Fig. 8e . We did not use high
Mg2q and Ni2q in this experiment, as these two
cations, besides protecting the RAECs, may exert
inhibitory effects on plasmalemmal Ca2q channels
w x20 .
Fig. 8. Agonist-induced Ca2q signaling was unaffected in high Ca2q-protected, CTX-treated RAECs. Single fura-2-loaded RAECs in
2q  . HBSS containing 1.2 or 7 mM Ca , with or without CTX 10 mM pretreatment for 20 min, were stimulated with bradykinin BK, 10
.  .  .mM a–c . The y-axis represents the fura-2 fluorescence ratio of 340 nmr380 nm. Results are quantified and shown in d . The ratio
increase at peak is taken as the difference between the pre-stimulation ratio and the highest ratio after agonist addition. The ratio increase
at tonic phase is the difference between the pre-stimulation ratio and the ratio at 12.5 min after agonist stimulation. Results are expressed
 .  .as the mean"SE of eight separate experiments. Similar protocols were done using ATP 100 mM as the agonist e . Results are the
mean"SE of ten–thirteen separate experiments.
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4. Discussion
Although there have been a number of publications
demonstrating the interactions of CTX with various
w xtypes of tissues 3 and its effect on the circulatory
w xsystem 14,15,18,21 , our report is the first to directly
demonstrate the cytotoxic actions of CTX on isolated
endothelial cells and the protection of these cells
from CTX-induced injury by divalent cations. Our
studies are of interest as endothelial cells are in
immediate contact with CTX once this toxin invades
the circulation. The uptake of trypan blue, membrane
necrosis, and substantial leakiness to Ca2q and Ni2q
observed in CTX-treated RAECs Figs. 1, 3, 6 and
.7 , consistently suggest that CTX caused elevation of
permeability to ions at the plasma membrane, eventu-
ally leading to membrane degeneration and cell death.
The percentage of cell death increased with the expo-
 .sure time to CTX Fig. 5 , a fact that is in concor-
 .dance with the variable lag periods 7–35 min be-
tween CTX application and the considerable rise in
plasmalemmal permeability to Ca2q and Ni2q in a
 .single RAEC Figs. 6 and 7 . These results suggest a
heterogeneity in the sensitivity of individual RAECs
 .to CTX. Our work presented here provides the first
report showing the effects of CTX at the single-cell
w xlevel. Tzeng and Chen 21 previously measured
w 2qxCa changes induced by CTX in single neonatali
w 2qxrat cardiomyocytes. Since the Ca responses werei
averaged over those obtained from a large number of
cell samples, this may account for their finding that
w 2qxCa rose gradually during the 10-min CTX treat-i
ment. Such averaged results may mask the variable
 w 2qxlag periods between CTX application and Ca i
.elevation in individual cells, as we observed in
 .single RAECs Figs. 6 and 7 . In our case, after the
w 2qxlag period in CTX-treated RAECs, Ca elevationi
was manifested as an abrupt ‘‘burst’’, with or with-
w 2qx out the preceding fluctuation in Ca Fig. 6a–b;i
.also, see below .
When RAECs were treated with CTX for 2 and 6
min, then washed extensively and checked for viabil-
ity after 13 and 9 min, respectively, the degrees of
cytotoxicity were similar to those checked immedi-
 .ately at the two time points Fig. 5 . These results
indicate that, first, those cells that CTX had already
damaged could not be recovered; second, those that
had not yet been damaged by CTX could be pre-
vented from cell death by extensive washing. Hence,
there appears to be a critical stage during CTX-in-
 .duced pore formation permeabilization , after which
membrane damage becomes irreversible. This pro-
posal is further supported by the observation that the
increase in plasmalemmal Ca2q permeability in
CTX-treated RAECs was abrupt, tremendous and was
 .followed by severe membrane disruption Fig. 6a–b .
At the latter ‘‘critical’’ moment, the plasma mem-
brane was damaged to an extent that Ni2q, which
 .usually does not permeate cells also see Fig. 7b ,
 .could rapidly enter the cytosol Fig. 7a .
High concentrations of Ca2q have been known to
inhibit CTX actions. For example, CTX-induced
hemolysis, contracture of skeletal muscles and guinea
pig papillary muscles were strongly suppressed by
2q w x)10 mM Ca 12,13,15 . In a consistent manner,
such high concentrations of Ca2q inhibited the bind-
ing of radiolabeled CTX to axonal membranes and
w xchick skeletal muscles 8,13 . In the present study,
when added prior to CTX, high Ca2q concentrations
completely suppressed CTX-induced cytotoxicity
 .Figs. 2 and 4 . It should be emphasized that such
high Ca2q concentrations merely represent an experi-
mental condition rather than a pathophysiological
situation. Suppression of CTX action could be mim-
icked by high concentrations of two other divalent
2q 2q  .cations, Mg and Ni Figs. 4 and 7 . The preven-
tion of CTX actions by high concentrations of diva-
lent cations has been demonstrated previously in
hemolysis, cytolysis and contractility studies
w x4,6,13,15 . All these data support the hypothesis that
CTX and Ca2q compete for the same anionic sites at
w xthe plasmalemma 4,13 . Such anionic sites may be
w x 2qlocated in the phospholipids 9,11 . If Ca competes
with CTX at the same sites, the activity of CTX
would be expected to be highest under Ca2q-free
conditions. It was, in fact, observed that the rate of
CTX-induced hemolysis and the binding of radiola-
beled CTX to erythrocytes were both enhanced when
Ca2q in the physiological saline was removed by
w xexcess EGTA 7,16 . Likewise, CTX-induced con-
traction in the rat skeletal muscle was enhanced in
2q w xCa -free medium 22 . However, in the same study,
CTX-induced contraction in human skeletal muscle
was considerably depressed in Ca2q-free medium. It
was also found that CTX-induced contracture in
guinea pig taenia coli was strongly attenuated under
( )Y.-J. Ou et al.rBiochimica et Biophysica Acta 1330 1997 29–38 37
2q w xCa -free conditions 23 . We observed that CTX-in-
duced cytotoxicity was much lower in Ca2q-free than
2q  .in 1.2 mM Ca -containing HBSS Fig. 2 . This
observation also suggests that Ca2q entry leading to
w 2qxthe elevation of Ca caused by CTX may not be ai
necessary condition to initiate cell damage; it is more
likely that it acts by aggravating the injury process
leading to cell death. It should also be noted that the
concentration of CTX also profoundly affects its
interaction with extracellular Ca2q and the subse-
 .quent damage eg. hemolysis at the plasma mem-
w xbrane 6 . We used 10 mM CTX throughout this
work, but other concentrations should be investigated
in future.
The prevention of CTX-induced plasmalemmal
leakiness by high Ca2q- and Ni2q concentrations is
illustrated in Figs. 6 and 7. There was no change in
basal fura-2 fluorescence at all in CTX-treated cells
protected by high Ca2q- or Ni2q concentrations, indi-
cating that no increases in permeability to Ca2q and
Ni2q had taken place. This experimental protocol,
while demonstrating how high concentrations of Ca2q
and Ni2q could prevent CTX-induced cytolysis, has
some advantages over previous methods, such as the
 .  2qhemolysis assay: 1 Small molecules i.e., Ca and
2q.Ni were used as ‘‘leakage markers’’ instead of
 .much bigger molecules such as hemoglobin; 2 the
fura-2 fluorimetric method offers a much more sensi-
tive and real-time measurement. Thus, our data fur-
ther confirm that high concentrations of divalent
cations can preserve the integrity of the plasma mem-
brane of CTX-treated cells.
CTX has been known to modulate the activities of
a number of enzymes at the plasma membrane. For
instance, studies using purified enzymes or isolated
membranes reveal that CTX inhibits NaqrKq-
ATPase, stimulates phosphatidylinositol 4-kinase, en-
hances Ca2q–Mg2q ATPase and adenylate cyclase
w x2,24–26 . Whether or not high concentrations of
Ca2q can prevent such modulatory activities by CTX
is unknown. Therefore, although the plasmalemmal
integrity of CTX-treated RAECs was preserved at
high concentrations of divalent cations, it still re-
mains unknown in such protected cells whether the
plasmalemmal enzyme activities were altered by CTX
or not. In line with this, there is no previous report
showing if high Ca2q-protected, CTX-treated cells
stay functionally intact or responsive to physiological
stimuli. One approach to solve this problem is to test
how well CTX-treated, high Ca2q-protected RAECs
could generate Ca2q signals in response to agonists.
Endothelial cells have been shown to express func-
 .tional ATP P - and P -purinoceptors and2U 2Y
 . w xbradykinin B and B receptors 27–29 . These1 2
 .receptors are coupled, via a G-protein G , toqr11
w xphospholipase C 30 , which cleaves phosphatidyl
inositol 4,5-bisphosphate to form inositol 1,4,5-tri-
 . w xsphosphate InsP and diacylglycerol 31 . InsP re-3 3
leases Ca2q from intracellular stores and, subse-
quently, the empty state of the stores stimulates
2q w xextracellular Ca entry 32,33 . The decline of a
Ca2q signal depends on the sequestration of Ca2q
back into the intracellular stores, and Ca2q extrusion
into the extracellular space achieved by the plas-
malemmal Ca2q pump andror the Naq–Ca2q ex-
w x 2q 2qchanger 34 . In high Ca medium, the Ca re-
sponses triggered by ATP and bradykinin in CTX-
treated groups were qualitatively and quantitatively
similar to those in the untreated control groups Fig.
. w 2qx8 , suggesting that there are intact Ca homeo-i
static mechanisms in CTX-treated cells. Therefore, in
high Ca2q-protected RAECs, CTX was unlikely to
have significant effects on plasmalemmal receptors
and Ca2q-handling machineries, and did not seem to
cause general adverse effects on plasmalemmal func-
tions. Intracellular Ca2q signalling plays an important
role in endothelial cell functions. For example, an
w 2qxincrease in endothelial Ca triggers the release ofi
vasoactive substances, such as prostacyclin, nitric
oxide and endothelin, which modulate the vascular
w xtone 17 . The preservation of functional integrity in
high Ca2q-protected CTX-challenged RAECs may
render the latter with the ability to control the con-
tractility of the underlying smooth muscles.
Acknowledgements
This work was supported by grants from the Hong
Kong Research Grant Council and the Heart and
Stroke Foundation of Ontario. CYK is a recipient of
the Heart and Stroke Foundation of Ontario. Y.M.L
is a recipient of the Croucher Foundation Postdoc-
toral Fellowship. S.J.H. and Y.J.O are visiting scien-
tists from the Department of Pharmacology and the
Department of Histology and Embryology, respec-
( )Y.-J. Ou et al.rBiochimica et Biophysica Acta 1330 1997 29–3838
tively, Sun Yat-Sen University of Medical Sciences,
Guangzhou, China. S.J.H was a recipient of the
Sino-British Trust Fund Visiting Fellowship.
References
w x  .1 E. Condrea, Experientia 30 1974 121–129.
w x  .2 J.L. Huang, W.R. Trumble, Toxicon 29 1991 31–41.
w x  .3 J.E. Fletcher, M.S. Jiang, Toxicon 31 1993 669–695.
w x4 W.W. Leung, W.M. Keung, Y.C. Kong, Naunyn. Schmiede-
 .berg’s Arch. Pharmacol. 292 1976 193–198.
w x5 C.L. Hinman, E. Lepisto, R. Stevens, I.N. Montgomery,
 .H.C. Rauch, R.A. Hudson, Toxicon 25 1987 1011–1014.
w x  .6 M.S. Jiang, J.E. Fletcher, L.A. Smith, Toxicon 27 1989
1297–1305.
w x  .7 L.P. Vernon, A. Rogers, Toxicon 30 1992 701–709.
w x8 J.P. Vincent, H. Schweitz, R. Chicheportiche, M. Fosset, M.
 .Balerna, M.C. Lenoir, M. Lazdunski, Biochemistry 15 1976
3171–3175.
w x9 O.S. Ksenzhek, V.S. Gevod, A.M. Omel’chenko, S.N. Se-
 .menov, A.I. Sotnichenko, Mol. Biol. Mosk. 12 1978
1057–1065.
w x10 P. Bougis, M. Tessier, J. Van Rietschoten, H. Rochat, J.F.
 .Faucon, J. Dufourcq, Mol. Cell. Biochem. 55 1983 49–64.
w x11 B. Gilquin, C. Roumestand, S. Zinn-Justin, A. Menez, F.
 .Toma, Biopolymers 33 1993 1659–1675.
w x  .12 Y.H. Chen, C.T. Hu, J.T. Yang, Biochem. Int. 8 1984
329–338.
w x13 S.Y. Lin-Shiau, M.C. Huang, C.Y. Lee, J. Pharmacol. Exp.
 .Ther. 196 1976 758–770.
w x  .14 A.L. Harvey, R.J. Marshall, E. Karlsson, Toxicon 20 1982
379–396.
w x15 S.J. Huang, C.Y. Kwan, Res. Commun. Mol. Pathol. Phar-
 .macol. 94 1996 103–110.
w x  .16 L.P. Vernon, A. Rogers, Toxicon 30 1992 711–721.
w x17 H.M. Himmel, A.R. Whorton, H.C. Strauss, Hypertension
 .21 1993 112–127.
w x18 K.H. Ho, C.Y. Kwan, S.J. Huang, J.P. Bourreau, FASEB J.
 .10 1996 A440.
w x19 J.E. Merritt, R. Jacob, T.J. Hallam, J. Biol. Chem. 264
 .1989 1522–1527.
w x20 B. Hille, in: Ionic channels of excitable membranes, Sin-
auer, Massachusetts, 1992, pp. 83–114.
w x  .21 W.F. Tzeng, Y.H. Chen, Biochem. J. 256 1988 89–95.
w x  .22 J.E. Fletcher, F.H. Lizzo, Toxicon 25 1987 1003–1010.
w x  .23 S.Y. Lin-Shiau, H.C. Huang, C.Y. Lee, Toxicon 24 1986
131–139.
w x  .24 C.C. Chen, S.Y. Lin-Shiau, Biochem. Pharmacol. 34 1985
2335–2341.
w x  .25 D.H. Walker, L.J. Pike, Biochim. Biophys. Acta 1055 1990
295–298.
w x  .26 W. Huang, L.P. Vernon, J.D. Bell, Toxicon 32 1994
789–797.
w x27 A. Bowden, V. Patel, C. Brown, M.R. Boarder, Br. J.
 .Pharmacol. 116 1995 2563–2568.
w x28 C. Brown, B. Tanna, M.R. Boarder, Br. J. Pharmacol. 116
 .1995 2413–2416.
w x29 J.A. Smith, C. Webb, J. Holford, G.M. Burgess, Mol.
 .Pharmacol. 47 1995 525–534.
w x30 S.P. Watson, D. Girdlestone, Trends Pharmacol. Sci. Recep-
 .tor and ion channel nomenclature supplement 7th edition
 .1996 54.
w x  .31 M.J. Berridge, Annu. Rev. Biochem. 56 1987 159–193.
w x  .32 M.J. Berridge, R.F. Irvine, Nature 341 1989 197–205.
w x  .33 J.W. Putney Jr., Cell Calcium 11 1990 611–624.
w x  .34 D.E. Clapham, Cell 80 1995 259–268.
